Positive Phase 2 Results for the VEGF Trap-Eye
- Details
- Category: Bayer
![Bayer AG Bayer AG](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Novartis and Massachusetts Institute of Technology (MIT) in new partnership
- Details
- Category: Novartis
![Novartis AG Novartis AG](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
Takeda to Sponsor Berlin Marathon 2007
- Details
- Category: Takeda
![Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited](http://www.worldpharmanews.com/images/stories/logo/takeda.gif)
Prix Galien USA Names HUMIRA Best Biotechnology Product
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
- Details
- Category: Bayer
![Bayer AG Bayer AG](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Anti-Tumor Activity of Single-Agent Sunitinib Malate in Advanced Gastric Cancer
- Details
- Category: Pfizer
![Pfizer Pfizer](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Start of the TALENT Study - a Unique Antihypertensive Study in Europe
- Nycomed and NPS Pharmaceuticals Announce Licensing Agreement for GATTEX™
- FDA Accepts sNDA for Expanded Use of Angiomax®
- Protherics licenses its Covaccine HT adjuvant to Nobilon for influenza vaccine indications
- Bristol-Myers Squibb to Acquire Adnexus Therapeutics
- Protherics signs ReGel⢠licensing agreement with Myungmoon Pharm
- Lundbeck in-licenses Circadin®, a drug approved for the treatment of primary insomnia